Concepedia

Kelli M. Wilson

KM

Statistics

Publications

45

Citations

2.2K

H-Index

24

Active since

2004

Affiliations

National Center for Advancing Translational Sciences(Current)

National Institutes of Health

National Cancer Institute

Center for Cancer Research

Frederick National Laboratory for Cancer Research

Kelli M. Wilson is an author at National Center for Advancing Translational Sciences specializing in medicine, oncology, and pharmacology.

Publications per year

2004–2025

45

Publications

45

RNA Polymerase II Regulates Topoisomerase 1 Activity to Favor Efficient Transcription

Laura Baranello, Damian Wójtowicz, Kairong Cui et al. · Cell · 2016 · 300 citations · Full text

Life Sciences, Genetics, Molecular Biology +12

Assay Guidance Manual [Internet]

Sarine Markossian, A Grossman, Kyle R. Brimacombe et al. · 2004 · 287 citations

Pharmacy, Pharmacology, Translational Sciences +17

Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening

Grant L. Lin, Kelli M. Wilson, Michele Ceribelli et al. · Science Translational Medicine · 2019 · 258 citations · Full text

Medicine, Oncology, Pharmacology +17

Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress

Anish Thomas, Nobuyuki Takahashi, Vinodh N. Rajapakse et al. · Cancer Cell · 2021 · 177 citations · Full text

Medicine, Molecular Biology, Oncology +14

Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2

Catherine Z. Chen, Paul Shinn, Zina Itkin et al. · Frontiers in Pharmacology · 2021 · 95 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

1–5 of 45